S&P 500   3,957.63
DOW   33,852.53
QQQ   280.57
Three Reasons It’s Time To Get Bullish On Organigram
Want To Catch The Next Hot Investing Trend (Look Inside?) (Ad)
The AP Interview: IMF head urges China to end mass lockdowns
Survivor of Virginia Walmart mass shooting files $50M suit
Want To Catch The Next Hot Investing Trend (Look Inside?) (Ad)
Build Your Quality of Life by Investing in Your Lifestyle
US stocks edge lower in unsteady trading, oil prices rise
Want To Catch The Next Hot Investing Trend (Look Inside?) (Ad)
Which Stocks Are Black Friday, Cyber Monday Winners & Losers?
Walmart employee who survived mass shooting at store in Virginia has filed a $50 million lawsuit against the company
S&P 500   3,957.63
DOW   33,852.53
QQQ   280.57
Three Reasons It’s Time To Get Bullish On Organigram
Want To Catch The Next Hot Investing Trend (Look Inside?) (Ad)
The AP Interview: IMF head urges China to end mass lockdowns
Survivor of Virginia Walmart mass shooting files $50M suit
Want To Catch The Next Hot Investing Trend (Look Inside?) (Ad)
Build Your Quality of Life by Investing in Your Lifestyle
US stocks edge lower in unsteady trading, oil prices rise
Want To Catch The Next Hot Investing Trend (Look Inside?) (Ad)
Which Stocks Are Black Friday, Cyber Monday Winners & Losers?
Walmart employee who survived mass shooting at store in Virginia has filed a $50 million lawsuit against the company
S&P 500   3,957.63
DOW   33,852.53
QQQ   280.57
Three Reasons It’s Time To Get Bullish On Organigram
Want To Catch The Next Hot Investing Trend (Look Inside?) (Ad)
The AP Interview: IMF head urges China to end mass lockdowns
Survivor of Virginia Walmart mass shooting files $50M suit
Want To Catch The Next Hot Investing Trend (Look Inside?) (Ad)
Build Your Quality of Life by Investing in Your Lifestyle
US stocks edge lower in unsteady trading, oil prices rise
Want To Catch The Next Hot Investing Trend (Look Inside?) (Ad)
Which Stocks Are Black Friday, Cyber Monday Winners & Losers?
Walmart employee who survived mass shooting at store in Virginia has filed a $50 million lawsuit against the company
S&P 500   3,957.63
DOW   33,852.53
QQQ   280.57
Three Reasons It’s Time To Get Bullish On Organigram
Want To Catch The Next Hot Investing Trend (Look Inside?) (Ad)
The AP Interview: IMF head urges China to end mass lockdowns
Survivor of Virginia Walmart mass shooting files $50M suit
Want To Catch The Next Hot Investing Trend (Look Inside?) (Ad)
Build Your Quality of Life by Investing in Your Lifestyle
US stocks edge lower in unsteady trading, oil prices rise
Want To Catch The Next Hot Investing Trend (Look Inside?) (Ad)
Which Stocks Are Black Friday, Cyber Monday Winners & Losers?
Walmart employee who survived mass shooting at store in Virginia has filed a $50 million lawsuit against the company
CVE:SVS

Solarvest BioEnergy - SVS Stock Forecast, Price & News

C$0.11
+0.01 (+10.00%)
(As of 11/29/2022 05:12 PM ET)
Add
Today's Range
C$0.11
C$0.11
50-Day Range
C$0.07
C$0.13
52-Week Range
C$0.04
C$0.26
Volume
61,511 shs
Average Volume
39,252 shs
Market Capitalization
C$6.09 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
SVS stock logo

About Solarvest BioEnergy (CVE:SVS) Stock

Solarvest BioEnergy Inc. engages in the development of algal-based production systems to produce natural based green commercial products in Canada and internationally. The company provides human nutrition products, including omega-3; and pharmaceutical ingredients for human health comprising cannabinoids in algae and bone morphogenetic protein for the treatment of repairing bone fractures. It has a collaborative research and development agreement with FSD Pharma Inc. to develop algae-based pharmaceutical grade cannabinoids. The company was incorporated in 2005 and is based in Vancouver, Canada.

Receive SVS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Solarvest BioEnergy and its competitors with MarketBeat's FREE daily newsletter.

SVS Stock News Headlines

Solarvest Files Quarterly Financial Statements and MD&A
Solarvest BioEnergy Inc.
See More Headlines
Receive SVS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Solarvest BioEnergy and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Conglomerates
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$109,686.00
Cash Flow
C$0.00 per share
Book Value
C($0.07) per share

Miscellaneous

Free Float
N/A
Market Cap
C$6.09 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Gerri J. Greenham (Age 71)
    Pres
  • Mr. Gerard Watts
    Interim Chief Financial Officer
  • Mr. Garth Greenham
    Chief Operating Officer
  • Mr. Claes Ellegaard
    CEO & Additional Director
  • Mr. Richard T. Groome BA (Age 63)
    Chairman of Financial Advisory Committee













SVS Stock - Frequently Asked Questions

How have SVS shares performed in 2022?

Solarvest BioEnergy's stock was trading at C$0.16 at the start of the year. Since then, SVS shares have decreased by 29.0% and is now trading at C$0.11.
View the best growth stocks for 2022 here
.

What is Solarvest BioEnergy's stock symbol?

Solarvest BioEnergy trades on the Canadian Venture Exchange (CVE) under the ticker symbol "SVS."

How do I buy shares of Solarvest BioEnergy?

Shares of SVS stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Solarvest BioEnergy's stock price today?

One share of SVS stock can currently be purchased for approximately C$0.11.

How much money does Solarvest BioEnergy make?

Solarvest BioEnergy (CVE:SVS) has a market capitalization of C$6.09 million and generates C$109,686.00 in revenue each year.

How can I contact Solarvest BioEnergy?

Solarvest BioEnergy's mailing address is 439 Helmcken St, VANCOUVER, BC V6B 2E6, Canada. The official website for the company is www.solarvest.ca. The company can be reached via phone at +1-604-6843323.

This page (CVE:SVS) was last updated on 11/30/2022 by MarketBeat.com Staff